• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西诺沙星在人体中的药理学。

Pharmacology of cinoxacin in humans.

作者信息

Black H R, Israel K S, Wolen R L, Brier G L, Obermeyer B D, Ziege E A, Wolny J D

出版信息

Antimicrob Agents Chemother. 1979 Feb;15(2):165-70. doi: 10.1128/AAC.15.2.165.

DOI:10.1128/AAC.15.2.165
PMID:426511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC352627/
Abstract

Cinoxacin was almost completely absorbed when given orally and was found to be approximately 60 to 70% protein bound. Peak serum concentrations were reached within 2 h, and detectable serum concentrations persisted up to 12 h after administration of 0.25-, 0.5-, and 1-g multiple oral doses. Although food delayed the absorption and caused a 30% reduction in mean peak serum concentrations, the overall 24-h urinary recovery was not significantly altered. Approximately 50 to 55% of the drug was excreted in the urine as unchanged drug. At 12 h, urine concentrations were still above the minimal inhibitory concentration for most common gram-negative urinary pathogens. Cinoxacin was well tolerated when administered to 23 volunteers from 10 to 28 days. Resistance among fecal isolates initially susceptible to cinoxacin was not observed in nine volunteers who were administered 0.5 g every 12 h for 4 to 28 days.

摘要

环丙沙星口服后几乎完全被吸收,发现其蛋白结合率约为60%至70%。口服0.25克、0.5克和1克多次剂量后,2小时内达到血清峰值浓度,给药后12小时内仍可检测到血清浓度。尽管食物会延迟吸收并导致平均血清峰值浓度降低30%,但24小时的总体尿液回收率没有显著变化。约50%至55%的药物以原形经尿液排泄。12小时时,尿液浓度仍高于大多数常见革兰氏阴性尿路病原体的最低抑菌浓度。对23名志愿者给药10至28天,环丙沙星耐受性良好。在每12小时服用0.5克、持续4至28天的9名志愿者中,未观察到最初对环丙沙星敏感的粪便分离株产生耐药性。

相似文献

1
Pharmacology of cinoxacin in humans.西诺沙星在人体中的药理学。
Antimicrob Agents Chemother. 1979 Feb;15(2):165-70. doi: 10.1128/AAC.15.2.165.
2
Influence of probenecid on serum levels and urinary excretion of cinoxacin.丙磺舒对西诺沙星血清水平及尿排泄的影响。
Antimicrob Agents Chemother. 1979 Mar;15(3):465-9. doi: 10.1128/AAC.15.3.465.
3
Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.口服给药后人体血浆、尿液和前列腺组织中的西诺沙星浓度。
Br J Urol. 1977 Apr;49(2):147-52. doi: 10.1111/j.1464-410x.1977.tb04089.x.
4
Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.尿液pH值对西诺沙星在人体内药代动力学及体外抗菌活性的影响。
Antimicrob Agents Chemother. 1982 Mar;21(3):472-80. doi: 10.1128/AAC.21.3.472.
5
Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.西诺沙星:一种新型合成有机酸的体外抗菌研究
Antimicrob Agents Chemother. 1975 Feb;7(2):159-63. doi: 10.1128/AAC.7.2.159.
6
Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.西诺沙星:肾功能正常和受损患者的药代动力学及耐受性
Antimicrob Agents Chemother. 1979 Sep;16(3):411-6. doi: 10.1128/AAC.16.3.411.
7
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.西诺沙星对2968株临床分离细菌的体外抗菌活性。
Antimicrob Agents Chemother. 1976 Jul;10(1):146-9. doi: 10.1128/AAC.10.1.146.
8
Microcalorimetric investigation of the action of cinoxacin against Escherichia coli.西诺沙星对大肠杆菌作用的微量热法研究
J Antimicrob Chemother. 1978 Jan;4(1):73-8. doi: 10.1093/jac/4.1.73.
9
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.西诺沙星和吡哌酸在人体中的比较药代动力学概况。
Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755.
10
Cinoxacin: pharmacokinetics and the effect of probenecid.西诺沙星:药代动力学及丙磺舒的影响
J Clin Pharmacol. 1978 Oct;18(10):491-9. doi: 10.1002/j.1552-4604.1978.tb01577.x.

引用本文的文献

1
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.联合或分开?揭示饮食干预对喹诺酮类药物生物利用度的影响:系统评价与荟萃分析。
Clin Pharmacokinet. 2024 Jun;63(6):773-818. doi: 10.1007/s40262-024-01377-0. Epub 2024 May 28.
2
Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.尿液pH值对西诺沙星在人体内药代动力学及体外抗菌活性的影响。
Antimicrob Agents Chemother. 1982 Mar;21(3):472-80. doi: 10.1128/AAC.21.3.472.
3
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.西诺沙星和吡哌酸在人体中的比较药代动力学概况。
Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755.
4
Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.西诺沙星。其药理学特性及治疗尿路感染疗效的综述。
Drugs. 1983 Jun;25(6):544-69. doi: 10.2165/00003495-198325060-00002.
5
Experiences on the efficacy and safety of nalidixic acid, oxolinic acid, cinoxacin and norfloxacin in the treatment of urinary tract infections (UTI).萘啶酸、恶喹酸、西诺沙星和诺氟沙星治疗尿路感染(UTI)的疗效及安全性经验。
Infection. 1984 Nov-Dec;12(6):377-80. doi: 10.1007/BF01645218.
6
Pharmacokinetics: metabolism and renal excretion of quinolones in man.药代动力学:喹诺酮类药物在人体内的代谢及经肾排泄情况
Pharm Weekbl Sci. 1986 Feb 21;8(1):29-34. doi: 10.1007/BF01975476.
7
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.茶碱维持治疗期间氧氟沙星、依诺沙星、环丙沙星和培氟沙星等喹诺酮类衍生物的稳态动力学
Drugs. 1987;34 Suppl 1:159-69. doi: 10.2165/00003495-198700341-00034.
8
Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.西诺沙星:肾功能正常和受损患者的药代动力学及耐受性
Antimicrob Agents Chemother. 1979 Sep;16(3):411-6. doi: 10.1128/AAC.16.3.411.

本文引用的文献

1
Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects.正常受试者中头孢菌素类抗生素的血液、尿液及组织浓度。
Postgrad Med J. 1971 Feb;47:Suppl:32-40.
2
Bacteriologic and pharmacodynamic aspects of nalidixic acid.萘啶酸的细菌学和药效学方面
J Urol. 1970 Dec;104(6):903-13.
3
Compound 64716, a new synthetic antibacterial agent.化合物64716,一种新型合成抗菌剂。
Antimicrob Agents Chemother. 1973 Oct;4(4):415-20. doi: 10.1128/AAC.4.4.415.
4
Serum protein binding of the aminoglycoside antibiotics.氨基糖苷类抗生素的血清蛋白结合情况。
Antimicrob Agents Chemother. 1972 Sep;2(3):214-6. doi: 10.1128/AAC.2.3.214.
5
Efficacy of cinoxacin in urinary tract infections.西诺沙星在尿路感染中的疗效。
Antimicrob Agents Chemother. 1976 Mar;9(3):502-5. doi: 10.1128/AAC.9.3.502.
6
In vitro activity of cinoxacin, an organic acid antibacterial.环丙沙星(一种有机酸抗菌剂)的体外活性
Antimicrob Agents Chemother. 1975 Mar;7(3):370-3. doi: 10.1128/AAC.7.3.370.
7
Antibacterial activity of cinoxacin in vitro.西诺沙星的体外抗菌活性。
Antimicrob Agents Chemother. 1975 May;7(5):688-92. doi: 10.1128/AAC.7.5.688.
8
Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.西诺沙星:一种新型合成有机酸的体外抗菌研究
Antimicrob Agents Chemother. 1975 Feb;7(2):159-63. doi: 10.1128/AAC.7.2.159.
9
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.西诺沙星对2968株临床分离细菌的体外抗菌活性。
Antimicrob Agents Chemother. 1976 Jul;10(1):146-9. doi: 10.1128/AAC.10.1.146.
10
Management of simple ureterolithotomy closure.单纯输尿管切开取石术切口的处理
Urology. 1977 Oct;10(4):310-1. doi: 10.1016/0090-4295(77)90156-x.